The Prague-based biotechnological start-up Elphogene has received an initial investment from i&i Prague in order to implement its oncoMonitor™, a liquid biopsy technology into a commercial assay for non-invasive diagnostic monitoring of patients in advanced stages colorectal cancer.
The company has been founded at the beginning of 2019 as a spin-off from the Genomac Research Institute.
Results & Experiences
We have been investigating ctDNA from patients' blood since 2009. We gained experience with patients with various types of cancer (lungs, pancreas, stomach, head and neck), but we found out the best application for colorectal cancer patients for whom oncoMonitor™ was primarily developed.
So far, in several extensive research studies, we have examined more than 500 such patients for the presence of ctDNA, and in at least 30 of them, we conducted long-term postoperative monitoring of ctDNA levels.
News & Media
Marek Minarik, PhD. presented the company Elphogene and the oncoMonitor™ test at the annual conference of the American Association for Cancer Research.
Marek Minarik, PhD. presented the company Elphogene and the oncoMonitor™ test at a multidisciplinary oncological congress in Prague, Czech Republic.
Marek Minarik, PhD. presented the latest data from clinical studies using liquid biopsies based on oncoMonitor™ technology in lung cancer patients at a conference in Miami, Florida, USA.
Scientists from Elphogene and the Genomac Research Institute in collaboration with leading oncology centers from the Czech Republic have published an article in an international scientific journal.
Marek Minarik, Ph.D. presented the company Elphogene in Prague, Czech Republic.
Marek Minarik, Ph.D. presented the company Elphogene in Brno, Czech Republic.
Marek Minarik, Ph.D. presented the company Elphogene in Pilsen, Czech Republic.
DNA helps diagnose cancer. The key is early detection.
Czech scientists present a unique technology to detect the relapse of colorectal cancer, which can prolong patients’ lives.
The invention of Czech scientists will reveal whether cancer returned to patients. Simply from the blood.
Czech scientists are developing a method to detect the return of cancer from just a few drops of blood.
Czech scientists have found out how to analyze blood to help cancer patients.
Czech scientists have developed new tests for cancer.